Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Wassman, Dganit Bar, David Suhy

Premium

Rosetta Genomics announced that it has named Robert Wassman as its new chief medical officer and Dganit Bar as its new chief scientific officer.

Wassman is a medical geneticist and has held various executive positions at companies including Genzyme Genetics. He most recently served as CMO at Generation Health.

Bar joins Rosetta from BioLineRx, where she served as executive director of science and technology. She also worked at QBI Enterprises, a subsidiary of Quark Pharmaceuticals.


Benitec Biopharma announced that Tacere Therapeutics' director of research and development, David Suhy, has been named its new senior vice president of research and development.

Suhy's appointment comes with Benitec's acquisition of Tacere.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.